瑞巴派特对阿司匹林诱导的小鼠小肠上皮屏障损伤的修复
本文选题:瑞巴派特 + 阿司匹林 ; 参考:《中国病理生理杂志》2017年09期
【摘要】:目的:探讨瑞巴派特能否通过促进肠道上皮屏障结构和功能的修复改善阿司匹林导致的小肠黏膜损伤。方法:本研究利用BALB/c小鼠,使用阿司匹林(200 mg·kg~(-1)·d~(-1))连续5 d灌胃的方法制作小肠损伤模型,并根据是否诱导小肠损伤及接受瑞巴派特(320 mg·kg~(-1)·d~(-1))的处理将小鼠分为正常对照组、模型组、瑞巴派特对照组及瑞巴派特治疗组。通过透射电镜、免疫组化、qPCR和Western blot等方法,在不同时点系统地观察瑞巴派特对阿司匹林所致的小鼠小肠黏膜损伤模型中小肠黏膜结构及屏障功能蛋白表达的影响。结果:阿司匹林所致的小肠黏膜损伤小鼠,经瑞巴派特(320 mg·kg~(-1)·d~(-1))连续5 d处理后,小肠上皮细胞间紧密连接结构的损害明显减轻,小肠组织中紧密连接蛋白ZO-1及occludin在mRNA及蛋白质水平的表达均明显增加(P0.05),环氧化酶2(COX-2)和增殖相关信号分子β-catenin、c-Myc的表达也高于对照组(P0.05),组织匀浆中前列腺素E_2浓度显著增加(P0.05),而COX-1的表达在治疗组中无明显改变。同时,治疗组血清中的D-乳酸水平明显降低(P0.05)。结论:瑞巴派特能够通过上调COX-2的表达,促进阿司匹林所致的小鼠小肠黏膜损伤的修复,改善肠屏障的结构与功能。
[Abstract]:Aim: to investigate whether repapet can improve the intestinal mucosal injury induced by aspirin by promoting the repair of intestinal epithelial barrier structure and function. Methods: in this study, BALB/c mice were perfused with aspirin (200 mg / kg) for 5 days to make the model of small intestine injury. The mice were divided into normal control group and model group according to whether to induce small intestine injury and to be treated with repapet (320 mg / kg) DX. Repapet control group and repapet treatment group. By means of transmission electron microscope (TEM), immunohistochemical staining (Western blot) and QPCR, the effects of repapet on the expression of mucosal structure and barrier protein in small and medium-sized intestine of aspirin induced intestinal mucosal injury in mice were systematically observed at different time points. Results: the damage of tight junction between intestinal epithelial cells in aspirin induced intestinal mucosal injury in mice treated with ribavirin 320 mg / kg / d for 5 days was significantly alleviated. The expression of ZO-1 and occludin in small intestine increased significantly in mRNA and protein levels, and the expression of cyclooxygenase 2 (COX-2) and proliferation-related signal molecule 尾 -cateninine c-Myc was also higher than that of control group (P0.05), and the concentration of prostaglandin E _ 2 in tissue homogenate was significantly higher than that in control group (P0.05), and the expression of 尾 -cateninine c-Myc in tissue homogenate was significantly higher than that in control group. The expression of COX-1 did not change in the treatment group. At the same time, the serum D-lactate level in the treatment group was significantly lower than that in the control group (P 0. 05). Conclusion: repapet can improve the structure and function of intestinal barrier by upregulating the expression of COX-2 and promoting the repair of small intestinal mucosal injury induced by aspirin in mice.
【作者单位】: 赣州市人民医院消化内科;中山大学孙逸仙纪念医院消化内科;
【基金】:国家自然科学基金资助项目(No.81370475)
【分类号】:R965
【相似文献】
相关期刊论文 前10条
1 李国锋;王春霞;晏媛;岸本展明;山本昌;;体外扩散池法评价瑞巴派特经大鼠肠黏膜的透过特性[J];药学学报;2008年03期
2 朱国峰,徐宏祥,臧芳玲;紫外分光光度法测定瑞巴派特片中瑞巴派特的含量[J];中国药业;2002年10期
3 李国锋;任非;山本昌;侯连兵;;月桂酸对瑞巴派特经大鼠结肠黏膜透过性的影响[J];中国现代应用药学;2008年06期
4 范鸣;;药物新适应证的开发[J];药学进展;2011年03期
5 李国锋;晏媛;周萍;周小祝;小泉勇人;山本昌;;肠溶性瑞巴派特壳聚糖胶囊的制备及大鼠口服给药吸收评价[J];沈阳药科大学学报;2008年10期
6 徐宏祥,周艳霞,傅应华;反相高效液相色谱法测定瑞巴派特及其片剂的含量[J];药物分析杂志;2001年05期
7 王静芳,徐宏祥,傅应华;一阶导数紫外分光光度法测定瑞巴派特片中瑞巴派特的含量[J];中国现代应用药学;2002年01期
8 汪大海,宋周虎,严洪,胡晓敏;高效液相色谱法测定瑞巴派特片含量[J];中国药师;2001年06期
9 俞蕴莉;张全英;黄明;华雯妍;王蒙;;HPLC-MS/MS法测定人血浆中瑞巴派特浓度的不确定度分析[J];中国医药科学;2013年22期
10 李国锋;王春霞;潘斌;刘静;晏媛;;HPLC梯度洗脱法测定大鼠血清和结肠组织中瑞巴派特的浓度[J];中国药房;2008年31期
相关会议论文 前1条
1 李国锋;侯连兵;任非;山本昌;;月桂酸对瑞巴派特经大鼠结肠粘膜透过性的影响[A];广东省药学会2007学术年会论文集[C];2008年
相关博士学位论文 前1条
1 史一杰;瑞巴派特纳米制剂及其黏膜保护作用的研究[D];沈阳药科大学;2012年
相关硕士学位论文 前2条
1 刘晨晨;瑞巴派特对大鼠非甾体类抗炎药相关性小肠损伤的保护作用及机制研究[D];南京医科大学;2016年
2 刁磊;瑞巴派特对NSAIDs肠病的保护作用及机制研究[D];安徽医科大学;2011年
,本文编号:1883052
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/1883052.html